EV Biologics, Inc. (YECO)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 48.9 Thousand | - | 118.9 Thousand | - | - | 9.47 Million |
| Cost of Revenue | - | - | - | - | - | 7.93 Million |
| Gross Profit | 48.9 Thousand | - | 118.9 Thousand | - | - | 1.53 Million |
| Operating Expenses | 531.96 Thousand | 590.04 Thousand | 143.15 Thousand | 98.96 Thousand | 98.4 Thousand | 1.38 Million |
| Selling, General and Administrative Expenses | 531.96 Thousand | 590.04 Thousand | 143.15 Thousand | 98.96 Thousand | 98.4 Thousand | 1.38 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | -102.46 Thousand |
| Cost and Expenses | 531.96 Thousand | 590.04 Thousand | 143.15 Thousand | 98.96 Thousand | 98.4 Thousand | 9.31 Million |
| Operating Income | -483.06 Thousand | -590.04 Thousand | -24.26 Thousand | -98.96 Thousand | -98.4 Thousand | 52.39 Thousand |
| Interest Expense | - | - | - | - | - | 576.38 Thousand |
| Income Tax Expense | -167.89 Thousand | -228.48 Thousand | -236.55 Thousand | -206.29 Thousand | -171.86 Thousand | 27.59 Thousand |
| Earnings before Tax | -1.26 Million | -21.05 Million | -387.69 Thousand | -98.96 Thousand | -98.4 Thousand | -523.98 Thousand |
| Net Income | -1.26 Million | -21.05 Million | -387.69 Thousand | -98.96 Thousand | -98.4 Thousand | -551.58 Thousand |
| Earnings Per Share Basic | -0.12 | -2.91 | -0.05 | -0.01 | -0.02 | - |
| Earnings Per Share Diluted | -0.12 | -2.91 | -0.05 | -0.01 | -0.02 | - |
| Weighted Average Shares Outstanding | 10.22 Million | 7.22 Million | 7.22 Million | 7.22 Million | 6.42 Million | 2.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.22 Million | 7.22 Million | 7.22 Million | 7.22 Million | 6.42 Million | 2.41 Million |
| Gross Margin | 1.00 | - | 1.00 | - | - | 0.16 |
| EBIT Margin | -25.91 | - | -0.20 | - | - | 0.08 |
| Profit Margin | -25.91 | - | -3.26 | - | - | -0.06 |
| EBITDA | -1.26 Million | -21.05 Million | -387.69 Thousand | -98.96 Thousand | -98.4 Thousand | -6.63 Million |
| Earnings Before Tax Margin | -9.88 | - | -0.20 | - | - | 0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 138.01 Thousand | - | - | 48.9 Thousand | 48.9 Thousand | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 138.01 Thousand | - | - | 48.9 Thousand | 48.9 Thousand | - |
| Operating Expenses | 52.59 Thousand | 191.54 Thousand | 11.2 Thousand | 531.96 Thousand | 424.7 Thousand | 215.89 Thousand |
| Selling, General and Administrative Expenses | 52.59 Thousand | 191.54 Thousand | 11.2 Thousand | - | 424.7 Thousand | 215.89 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 52.59 Thousand | 191.54 Thousand | 11.2 Thousand | 531.96 Thousand | 424.7 Thousand | 215.89 Thousand |
| Operating Income | 85.42 Thousand | -191.55 Thousand | -11.2 Thousand | -483.06 Thousand | -375.8 Thousand | -215.9 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | -43.27 Thousand | -167.89 Thousand | -43.81 Thousand | 39.58 Thousand |
| Earnings before Tax | 85.42 Thousand | -191.54 Thousand | -197.69 Thousand | -1.26 Million | -235.7 Thousand | -377.91 Thousand |
| Net Income | 85.42 Thousand | -191.54 Thousand | -197.69 Thousand | -1.26 Million | -235.7 Thousand | -377.91 Thousand |
| Earnings Per Share Basic | 0.01 | -0.02 | -0.02 | - | -0.02 | -0.05 |
| Earnings Per Share Diluted | 0.01 | -0.02 | -0.02 | - | -0.02 | -0.05 |
| Weighted Average Shares Outstanding | 10.22 Million | 10.22 Million | 10.22 Million | 10.22 Million | 10.22 Million | 7.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.22 Million | 10.22 Million | 10.22 Million | 10.22 Million | 10.22 Million | 7.22 Million |
| Gross Margin | 1.00 | - | - | 1.00 | 1.00 | - |
| EBIT Margin | 0.62 | - | - | - | -7.69 | - |
| Profit Margin | 0.62 | - | - | -25.91 | -4.82 | - |
| EBITDA | 85.42 Thousand | -191.55 Thousand | -11.2 Thousand | - | -375.8 Thousand | -215.9 Thousand |
| Earnings Before Tax Margin | 0.62 | - | - | -9.88 | -7.69 | - |
PLNTQ
7832
RATO-A
EIX
PEP
000599